Saturday, November 29, 2014

Shell Job Recruitment... Shell is looking to recruit in Nigeria - Apply Now!

Shell is looking to recruit an experienced Investigation Case Manager. The purpose of this position is to typically conduct investigations of a higher complexity level with minimum support and coaching required, manage cases and support others in the department in conducting cases, preferably working from Port Harcourt, Nigeria.
Auto req ID: 10713BR
Job Title: Investigation Case Manager
Country of Work Location: Nigeria
Work Location: Port Harcourt
The Company
Shell Nederland BV is a platform for international collaboration, with Shell offering direct employment to around ten thousand people in the Netherlands alone, including roughly 2,800 non-Dutch employees from around 80 countries. Diversity is key at Shell Nederlands, and our employees reflect the innovation that stems from a diverse workforce. By joining Shell Nederland, you will benefit from an unrivalled industry-leading development programme that will see you tap into a pool of expert knowledge that will help propel your career. Shell Nederland is the holding company of most Shell companies operating in the Netherlands. Shell Nederland also has an advisory and coordinating role in numerous areas.
Job responsibilities
The role’s primary objective is to support and conduct investigations into potential breaches of the Code of Conduct, company policy and the law to maximize success and minimize liability and to effectively facilitate management decision-making including consequence management. Investigations may involve, but are not limited to, fraud, theft, bribery and corruption, conflict of interest, anti-trust and may involve employees, contract employees, vendors/suppliers and others.
The role’s secondary objective is to identify internal control weaknesses and quantifying any possible losses, as well as utilising forensic data analytic tools to identify relevant indicators.
Position requirements
► You are a Qualified accountant (e.g. RA, CPA, ACCA) with accounting, financial, economics and/or business administration qualification,
► An experienced investigator with previous substantial law enforcement experience in conducting investigations into fraud or financial crime or forensic accountant with a university degree (Bachelors but ideally a Masters) in accounting/Finance or law with a minimum of ten years’ experience.
► Strong analytical skills, the ability to provide Civil/Criminal testimony regarding your work product, familiarity with electronic data systems and data collection, unquestioned honesty and integrity, excellent interpersonal skills and the ability to maintain a high level of objectivity.
► Experience in conducting data analytics would be a major advantage. Accounting/Legal, Contracting & Procurement, Finance, IT or project management skills and experience within a major corporate would also be an advantage.
► Must be able to self-manage the case load and pick up more senior stakeholder engagements.
The Shell Group and its approved recruitment consultants will never ask you for a fee to process or consider your application for a career with Shell. Anyone who demands such a fee is not an authorised Shell representative and you are strongly advised to refuse any such demand.
Shell is an Equal Opportunity Employer.
To Apply
Click Shell Group_Career HEREhttps://krb-sjobs.brassring.com/tgwebhost/jobdetails.aspx?partnerid=30030&siteid=5798&jobid=750150

Fresh Graduate Job Vacancy at Etisalat-Abuja, Nigeria


Emerging Telecommunications Etisalat Nigeria has established itself in the Nigeria telecommunication market since its inception. Etisalat is currently recruiting for the position of :
Job Title Analyst.SIM Registration (regional)
Location Abuja,NG
Job Summary
Provide operational and administrative support to the Regional Distribution Manager (dotted line to Manager-SIM Registration Operations) to ensure smooth day-to-day running of SIM Registration teams in assigned Region
Principal Functions
Ensure implementation of processes and procedures guiding activities of SIM Registration Officers (SROs) in assigned Region to ensure delivery on set subscriber registration targets
Assist Regional Distribution Manager to manage SIM Registration Supervisors in assigned Region
Ensure responsible usage and safekeeping of all SIM Registration equipment/ tools in assigned Region
Provide and co-ordinate first-line systems support for SIM Registration issues in assigned Region
Ensure timely escalation and resolution of all SIM Registration-related issues and queries in assigned Region
Assist SROs in timely pooling of registered subscriber data to central server and escalate all factors/ challenges adversely affecting the achievement of pooling targets
Track, audit and visit Trade and SIM Registration outlets and hot-spots
Prepare and ensure timely delivery of all reports required from SIM Registration outlets for attention of Regional Distribution Manager and SIM Registration Operations Manager
Gather information on competition activities in SIM Registration and collate information for attention of HQ team
Perform any other duties as assigned by the Specialist-SIM Registration Operations
Educational Requirements
First degree or its equivalent in a relevant discipline
Experience,Skills & Competencies
Minimum of one year post NYSC relevant work experience.
APPLY NOW
 http://careers.etisalat.com.ng/OA_HTML/OA.jsp?page=%2Foracle%2Fapps%2Firc%2FcandidateSelfService%2Fwebui%2FVisVacDispPG&OAHP=IRC_EXT_SITE_VISITOR_APPL&OASF=IRC_VIS_VAC_DISPLAY&akRegionApplicationId=821&transactionid=1185080438&retainAM=N&addBreadCrumb=RP&p_svid=1802&p_spid=30900&oapc=5&oas=2RwDP2sClVJhR3DFpvzvPg

Friday, November 28, 2014

INEC Jobs, INEC recruitment 2014 nationwide

INEC recruitment for New Applicants AND Returning Applicants in 2011
In view of the above, eligible staff from our partner agencies/organisations are requested to fill the position stated below. Meanwhile, those who had earlier enrolled in the 2011 General Elections can update their submissions accordingly.
INEC invites applications from suitably qualified candidates to fill the position below:
Job Title: Assistant Presiding Officer
Location: Nationwide
The Requirements / Eligiblity
Must be a serving NYSC Member.
Student of penultimate year in Federal Tertiary Institutions.
Former NYSC Members that participated in Electoral Activities (2011-date) and
Federal Government Employees Grade Level 07-09 at State Level possessing minimum of National Diploma / equivalent.
Job Title: Presiding Officer
Location: Nationwide
Requirement / Eligiblity
Must be a serving NYSC Member.
Job Title: Supervisory Presiding Officer
Location: Nationwide
The Requirements / Eligiblity
Must be an INEC Staff or Federal Public Servant (Ministries, Departments and Agencies) Grade Level 10-14 at State Level.
Job Title: Local Government Area (LGA) Collation Officer
Location: Nationwide
The Requirements/Eligiblity
Must be a Lecturer of a Federal Tertiary Institution or Member of the following Professional Associations (NMA, ANAN, PSN, NSE, NIA, NIQS).
Job Title: State Constituency Returning Officer
Location: Nationwide
The Requirements/Eligiblity
Must be a Serving Vice Chancellor of any University or Retired Justice/Judge of Federal High Court.
Job Title: Senatorial/National and State Constituency Returning Officer
Location: Nationwide
The Requirements/Eligiblity
Must be a Serving Professor in any Federal Tertiary Institution or Retired Justice/Judge of Federal High Court.
Job Title: Senatorial/National and State Constituency Returning Officer
Location: Nationwide
The Requirements/Eligiblity
Must be a Serving Professor in any Federal Tertiary Institution or Retired Justice/Judge of Federal High Court.
How to Apply
Qualified and interested candidates should:
New Applicants: http://iasd.inecnigeria.org/new-applicant
Returning Applicants:  http://iasd.inecnigeria.org/returning-applicantApplication Deadline 11th December, 2014.
The Independent National Electoral Commission (INEC) is set to revalidate and update its Ad-hoc Staff Enrolment Databank in preparation for the forth-coming 2015 General Elections.

RANDOM MUSINGS: THE SHOW-DOWN BETWEEN DR. EMMANUEL EWETA UDUAGHAN AND SENATOR JAMES MANAGER WILL BE THE TRUE LITMUS TEST OF NIGERIA’S DEMOCRACY


Francis Akenami - 11/28/14 8:52 AM

Why don’t Nigerian politicians believe in the instrument that brings them to power: the right to vote and be voted for, the most popular candidate wins, which we simply refer to as democracy? When the military was in power, many people fought them almost to a standstill. Many lost their lives. Today we remember people like MKO Abiola, Kudirat Abiola, Chief Rewane of Warri, Wole Soyinka, Gani Fawehinmi, Ogaga Ifowodo just to mention the few I remember. The military never believed in democracy. The military believed in the power that blazed forth from the blood drenching barrels of their guns. At last, we got democracy; but at what price? What are we doing now?


Itsekiri (sorry, I actually mean, HE. Dr. Uduaghan) is in charge of Delta State and by extension DSIEC. DSIEC does not believe in free-and-fair elections. Every position must be won by PDP, whether elections we conducted or not.

INEC: The Official Website

The Registers of Voters are now on the website, for intending voters to check their status before Election Day. The registers will be updated after the Continuous Voter Registration (CVR) . To check your name on the Register of Voters, CLICK HERE

Thursday, November 27, 2014

Economy Watch: As the Price of Crude Oil Continues on a Free Fall

Today, I wish to inform the House that the world, especially Oil Producing Countries is in a panic. The price of crude oil is in free fall. About two weeks ago I predicted economic crunch for Nigeria in 2015. Just two days ago Nigeria devalued its naira from 1USD to N155 to 1 USD to N168. While the Governor of the Central Bank of Nigeria said it is to strengthen the economy, it is not true or even correct. Any seasoned economist here can challenge me to that. Nigeria exports majorly crude oil (and barely nothing else) and the price is now 68 USD per barrel falling all the way from 150 USD. Nigerians should tighten their belt and brace for the hardship that will come. However, because we are used to hard life, the ordinary Nigerian may not notice the impact immediately. The result will be inflation, then hyper-inflation. The Organisation of Petroleum Exporting Countries (OPEC) today threatened a shut-down of further crude oil productions. Nigeria should brace up for the tight times. Our leaders should come up with strategic economic policies to bail us out of our dwindling fortunes. I predict here today that the naira will be devalued again shortly. This situation is caused primarily by the United States of America producing about 14 million barrels of crude oil per day. America has never sold crude oil before, there are now plans for the Nation to sell 1 million barrels of crude oil per day. The pump price of gasoline has been falling steadily in USA for two months now. We need to act fast.

Mrs. Diezani Alison-Madueke Elected First OPEC Female President

271114l.ALISON-MADUEKWE.jpg - 271114l.ALISON-MADUEKWE.jpg
Minister of Petroleum Resources, Mrs. Diezani Alison-Madueke
Chineme Okafor in Vienna, Austria
The Minister of Petroleum Resources, Mrs. Diezani Alison-Madueke, has been elected the first female president of the Organisation of Petroleum Exporting Countries (OPEC).
Alison-Madueke was  elected President of OPEC Thursday at the ongoing 166th General Meeting of the body in Vienna, Austria.
She replaces former President of OPEC, Libyan Vice Prime Minister for Corporations, Abdourhman Atahar Al-Ahirish.

Merck’s Entry Marks Third Big Pharma In Ebola Vaccine Race.



Vauhini Vara writes for the New Yorker (11/26) that Merck’s freshly-inked deal with NewLink Genetics over the latter company’s promising Ebola vaccine means that it joins GSK, J&J, and several startups in a test of R&D as the companies try to win the first broad approval. With only a handful of cases in developed countries, Ebola does not have much promise of profit in the traditional drug discovery and development model, but public payers are poised to stockpile large volumes of approved vaccines and therapeutics. Compared to blockbuster vaccines like Merck’s Gardasil, Ebola is likely to generate small profits at best. The New Yorker offers two reasons for Merck’s deal: “it was seen as a promising drug and had features in common with other Merck vaccines, and Merck had experience in developing and producing vaccines that NewLink, as a much smaller company, lacked.”
        Trefis (11/26) agrees that an Ebola vaccine is unlikely to create a blockbuster for Merck, writing “the incremental value addition from a successful launch and commercialization will be low considering Merck’s size and our expectation that the price of vaccine is likely to be low.” Zacks Investment Research (11/26), meanwhile, calls the acquisition” a smart move.”
        Chemical & Engineering News (11/26, Halford) reports that, in contrast to the two doses believed to be required for Glaxo’s ChAd3 vaccine to be effective, Merck/NewLink’s VSV-EBOV should work with only one jab. The difference could be a boon for Merck, as the vaccine is supposed to be deployed in areas with limited healthcare infrastructure or in wealthier countries experiencing a public health crisis. In addition to vaccine R&D, intensive efforts are also underway by numerous companies to develop treatments for those already infected and to produce a fast, cheap, and reliable test for the condition.
        GSK Vaccine Trial Underway. TIME (11/26, Sifferlin) gives an update on the status of one of two experimental Ebola vaccine trials being tested in humans. GlaxoSmithKline and NIH partnered to develop a vaccine being tested at the University of Maryland School of Medicine, University of Oxford, Emory University, and in the field in Mali. Healthy volunteers have already been given the vaccine and researchers are waiting for the 28th day after injection for data, as this is the date at which the immune response would be the strongest due to the vaccine. Researchers hope to bring this vaccine to the WHO by the end of December.
        The Baltimore Sun (11/26, Dance) profiles volunteers who signed up to test the Ebola vaccine at University of Maryland. Volunteers report high fevers immediately following injection and feeling “exhausted.” The Sun reports that volunteers cannot catch Ebola from receiving the vaccine because the vaccine does not contain the virus. Instead, the vaccine uses chimpanzee cold virus to trick the immune system into creating antibodies for Ebola. NIH will compare the results from these volunteers to results in monkeys who were given the vaccine and subsequently exposed to Ebola. Nancy Sullivan, chief of the biodefense research section of NIAID said about the testing, “Unless you have a crystal ball that is well maintained, you can’t really predict how any of these things will perform in humans. ... It’s cautious optimism.”
        Analysis: GeoVax Needs Partner For Ebola Vaccine. A November 18 analysis (off embargo today) by Edison’s Philippa Gardner and Mick Cooper explored GeoVax, a tiny biotech working on a one-shot Ebola vaccine. The company is trying to find a partner, possibly the CDC, to help it test the vaccine (experimental name GOVX-E301). Edison noted that, with a current valuation of $5.6 million, “current cash will be insufficient for further development.” Analysis based on embargoed market research from Thomson Reuters.

Wednesday, November 26, 2014

Dr. Kingsley Emu

Join me to thank this man who served Delta State meritoriously as the erstwhile Delta State Commissioner for Commerce & Industry: Dr. Kingsley Emu. He is an accomplished businessman and intellectual. As Commissioner he was one of the few that responded to e-mail messages almost immediately when we worked together under the platform of OneStopShop to attract investors. He supported Olomoro Telescope quietly during the fund-raiser for the OCHS Computer Lab. What matters is not "I am still there" as everyone will certainly become ex-this, ex-that, but how many lives you touched while there. Thank you very much good man!

Tuesday, November 25, 2014

US Executive Actions on Immigration

Executive Actions on Immigration

On November 20, 2014, the President announced a series of executive actions to crack down on illegal immigration at the border, prioritize deporting felons not families, and require certain undocumented immigrants to pass a criminal background check and pay taxes in order to temporarily stay in the U.S. without fear of deportation.
These initiatives include:

Saturday, November 22, 2014

CONGRATULATORY ADVICE TO SIR CONSTANTINE IKPOKPO, CHAIRMAN, ISOKO SOUTH LOCAL GOVERNMENT COUNCIL.

 By Barr. Mike Edegware

 My dear Chairman,
A post election congratulatory message is a normal course of action and is therefore not unexpected, particularly of those whose modest contributions and support aggregated to the victory that is being celebrated
To me and indeed a host of your other friends, it is no news that you won the election. However, the contrary would have made front page news, given your huge support base and the political arsenal at your disposal going into the contest. Having won, knowing what to do with your mandate and how to go about it are the next challenges which you must confront frontally.
To many, a manifesto is a list of promises designed to attract political support, but which is consigned to the garbage bin once the election is over. To me,it is much more than that. I see a manifesto as an article of faith, the covenant between the elected and the electorate; indeed an integral and core part of the oath of office which must guide and moderate your conduct all through your tenure, particularly the equitable application of the People's resources, the proud custodian of which you are privileged to be.

Friday, November 21, 2014

Gates Pledges $5.7M To Convalescent Serum Project To Cure Ebola.

The Los Angeles Times (11/20, Morin) reports in-depth on the Bill and Melinda Gates Foundation’s $5.7 million commitment to convalescent serum as a cure for Ebola. On Tuesday, Gates announced the project, which will collect plasma from the blood of Ebola survivors, treat it with pathogen inactivation technology to prevent the transmission of other diseases, and then administer it to Ebola patients. The Times adds that the FDA has not approved the pathogen inactivation drug, INTERCEPT, developed by Cerus Corp., though it did authorize the use of the drug in this project.
Amesh Adalja, researcher at the University of Pittsburgh Medical Center, told USA Today (11/19, Szabo) that plasma treatments from disease survivors have never actually been tested in clinical trials, though doctors have been using the practice to treat Ebola since the disease first appeared in the 1970s.
Senate HELP Committee Passes Bill To Speed FDA Approval Of Ebola Drugs. The Hill (11/20, Viebeck) reports that on Wednesday the Senate Health, Education, Labor, and Pensions Committee approved S. 2917, which hastens the approval process of Ebola drugs by the FDA. The House has not passed its version of the bill through committee yet.
Columnists Call For Public-Private Partnership To Develop Ebola Drugs. In a column for USA Today (11/19, Von Eschenbach, Howard), Dr. Andrew von Eschenbach, former commissioner of the FDA, and Paul Howard, director of the Manhattan Institute’s Center for Medical Progress, argue that the reason why we do not yet have proven treatments for Ebola is because of a lack of funding. Developing effective treatments for infectious disease is too expensive for governments to tackle on their own, they write. The columnists call on Congress to pass a public-private partnership initiative to facilitate the development of Ebola and bioterrorism drugs.
Analyst: Increased Research Funding Necessary To Develop Ebola, Infectious Disease Treatments. Roll Call (11/20, Subscription Publication) published an op-ed by Claire Pomeroy, president of the Albert and Mary Lasker Foundation, who calls on the US to fund initiatives to get ahead on research for infectious diseases, saying that after Ebola, a novel virus is inevitable. Pomeroy praises Sens. Orin Hatch and Elizabeth Warren for their proposal to fund NIH with $1 billion annually for the next 10 years, but cautions that even that amount of funding may not be sufficient.

Thursday, November 20, 2014

THE EXIT OF A SAGE: THE NEW YORK EXPERIENCE

High Chief. Dr. Abel K. Ubeku, LLM, PhD, OFR (February 24, 1936 – March 9, 2014)
By Dr. Francis Akenami.
I write this tribute on behalf of the Isoko people in New York, USA and indeed all Isokos in diaspora. Much of what I know about Dr. Ubeku is through my interactions with him in New York. An hour with him spells courage, charm, determination, frank talk, inspiration and deep knowledge of various Nigerian issues. He was fun to spend time with as he was never short of words and answers to different searching questions. He mingled with the Isoko people in New York freely and would always ask us to check on him whenever we visited Nigeria. True to type, I visited him in Araya and he received me with all the warmth at his disposal.

Vacancies For Graduate Trainees At Grant Thornton International Ltd

Jobs Vacancies, B.Sc/HND Needed... Vacancies For Graduate Trainees At Grant Thornton International Ltd
Vacancies For Graduate Trainees At Grant Thornton International Limited
Positions Require: Fresh graduates ( No experience required)
Grant Thornton Nigeria seeks interested young, dynamic graduates (Post NYSC) of any of the disciplines indicated below to fill entry level position of Graduate Trainee in their Abuja, Lagos and Port-Harcourt branch
Grant Thornton An instinct for growth
Vacancies For Graduate Trainees
Our Company Grant Thornton Nigeria is a member firm of Grant Thornton International. Grant Thornton is one of the world's leading organizations of independent Audit & Assurance, Tax and Advisory Firms, with offices in over 130 countries.
As part of its People and culture development policy, Grant Thornton Nigeria with presence in Abuja, Lagos and Port-Harcourt presently seeks interested young, dynamic graduates (Post NYSC) of any of the disciplines indicated below to fill entry level position of Graduate Trainee.
Position Requirements:
Fresh graduates ( No experience required)
B.Sc Graduates of Accountancy, Economics, Banking & Finance, Mathematics, Statistics, Business Administration, Computer Science, Engineering or other related numerate disciplines.
Minimum of second class upper division
Good, passionate inter-personal skill and ability to work effectively in a team
Excellent oral and written communication skills
Smart, intelligent and likeable disposition
Analytical and lateral thinking skills
Passion for research and learning
Not more than 25 years of age
Location:
Abuja, Lagos, Port-Harcourt
How to apply:
Qualified candidates are invited to apply by submitting their updated CVs and cover letter indicating preferred location to recruitment@ng.gt.com not later than two weeks from the date of this publication.
Please note that only shortlisted candidates will be contacted.
Grant Thornton Nigeria is a member firm of Grant Thornton International Limited (GTIL). GTIL and the member firms are not a worldwide partnership Services and delivered by the member firms. GTIL and its member firms are not agent of and do not obligate one another and are not liable for one another's acts or omissions. Please see www.grantthornton.com.ng for further details.

Wednesday, November 19, 2014

Jobs Vacancies in global upstream industry

Vacancies
Our client service provider to the global upstream industry. Being recognised for their integrated subsurface and commercial solutions to the international Oil & Gas arena, they have an outstanding reputation second to none in the region.
Applications are invite for the following vacant positions in our Regional Offices.
Vacancy - Workshop Manager
B.Sc Elect/Mechanical Engineer, COREN Registered,computer literate with 10 years industrial experience.
Vacancy - Store Officer/Controller
5 Years purchasing experience with stock control and must be computer literate.
Vacancy - Electro/Diesel Mechanic
B.Sc/HND with 10 years experience,Computer literate
Vacancy - Hiab Motor Driver
Full driver License with 5 years experience.
Vacancy - Diesel Mechanic
Trade Test,Grade 1 and 5 years experience with Driving licence.
Vacancy - Electrical Installation Technician
Trade Test,Grade 1 with 5 years experience.
Vacancy - Plant Engineers
BSC/HND,Computer literate with experience on Heavy Duty Marine Engine,10 years work experience.
Vacancy - Mechanical/Power Engineer
B.Sc/ HND With 5 years experience, COREN Registered,Computer literate.
All suitable candidates to submit applications/CV with Photocopies of credentials with two weeks of this publication to:
P.O. BOX 353 SURULERE,LAGOS.
Or
E-mail: vi@stagengineering.com

Tuesday, November 18, 2014

$ 16bn EPZ Saga: Uduaghan Decries Attack on Jonathan, Abduction of Journalists



From left, Secretary to Delta State Government, Comrade Ovuozourie Macaulay, Governor Emmanuel Uduaghan of Delta State and President, Nigeria Guild of Editors, Mr. Femi Adesina during the 2014 Delta NUJ Press Week held in Asaba, Tuesday.

LAGOS NOVEMBER 18TH (URHOBOTODAY)-Delta State Governor, Dr Emmanuel Uduaghan has decried accusations leveled on President Goodluck Jonathan of being partisan in the issue of the Delta Gas City project, Ogidigben, saying, the President means well for Nigerians.
He also, strongly condemned the recent kidnap of fourteen journalists in some parts of Delta State, stating that the President was worried as a result of the incident and has charged security operatives to unravel what happened.

Christmas Gift from ENTOURAGE SOLUTIONS

Christmas Gift from ENTOURAGE SOLUTIONS is out! Get the latest BUSINESS Plan simplified Software @ #2,000 and its Mentorship FREE. Order yours today. For inquiry contact us @ entouragest@gmail.com, info@entourage-ng.com, or call: 07067009946. See you @ the top...!

Great deals you can't resist.

"You don't wait to buy land, You buy land and wait"
a) 2 Plots (1234sqm) of land available at Shapati, Ibeju Lekki, Lagos. Title: Deed of Assignment, Survey Plan and Gov Consent. Price: N12m (N6m per plot).
b) The plot is situated at Ado -Soba in Abule-Ado, Amuwo Odofin L.G.A. It's a virgin land with corner piece. It's in a fast developing site and there is proximity from the location to some part of festac.
It has a survey plan, family receipt of purchase and dead of assignment. It's going for just N2m. It is a standard plot with 648sqm size.
c) 2 plots in PHC @ Alakahia, with CofO and already fenced for N10m.
d) All Rooms Ensuite 4 Bedroom Bungalow located in Lokoja, Kogi State with a Sit-out, Generator house, a Gate House and a Garden. ‪#‎55M‬ asking.
e) Filling Station at Yaba Oyinbo of Railway Ebute Meta on 3plots with 8pumps.
Price: N500m. Tittle- C of O
6) 2 twin bungalow of 3 bedroom flat on 3 plots, fully fenced goes for N25m at Ibeju Lekki, Lagos.
7) Estate Plots available in Lekki Ibeju, Epe, Agbara, Mowe Ofada, Simawa & Abuja axis. Installment payment plan available as low as N15,100.
For more info, call
Rebaznet Homes on
08097454236, 08085527292.
BBM: 798FECA5
E: rebaznet13@gmail.com

The Petroleum Training Institute

The Petroleum Training Institute Effurun has advertised for vacancies. Pls see Vanguard of 17/11/14 page 49. Captioned Public Service Instutute of Nigeria. Interested applicants should Pls send their application with CV to www.recruitment.psinportal.com

Sunday, November 16, 2014

END OF THE NIGERIAN ECONOMIC BOOM?


Francis Akenami
2015 may not be well with the Nigerian mono-dependent oil economy. Please expect some economic crunch for the following reasons:
1. Since the Government of General Olusegun Obansanjo in 1998, that is, about 16 years ago, the price of a barrel of crude oil varied from a high of about 150 USD to a low of 100 USD/barrel. That was a wonderful boom. However, its coming to an end through no fault of ours.
2. The Government of the United States of America discovered an unconventional crude oil reserve known as shale oil. Yes, the government started working on it quietly. Boy-o-boy!
3.Today the United States of America is producing 7million barrels of crude oil per day and has overtaken Saudi Arabia to become the number one crude oil producer of the world.
4. For about one month now, the price of gasoline (petrol) has fallen in USA. What is the reason, America now produces enough crude oil for local consumption and has stopped buying crude oil from Nigeria. Nigeria is now looking for buyers everywhere in the world. In a panic, Saudi Arabia has slashed crude oil prices.
5. Today the International crude oil platt price is 70 USD per barrel, which is just half the price it was about 16 years ago.
6. The Americans are happy and smiling to the bank including yours sincerely, as I now pay less to fuel my car.
7. Africa wake up, the end is near.
----------------------------------------------------
U.S. Seen as Biggest Oil Producer After Overtaking Saudi Arabia
By Grant Smith Jul 4, 2014 4:56 PM GMT+0100

DELTA TALENT: ZUBBY ENEBELI AND THE MASTER’S TOUCH BAND

Zubby Enebeli is a Nigerian musical star well-gifted in the art of musical entertainment and working audiences to a frenzy. Very humble and unassuming, he is a graduate of the Kaduna Polytechnic, and has several albums to his credit. He is the MD/CEO of the Zubino’s Event Centre, Asaba, Delta State, Nigeria. He Runs a 17-man full orchestral band, specializing in entertaining at end of year parties, birthday parties, government events and other engagements too numerous to mention.

Saturday, November 15, 2014

THE FASTEST ANIMAL IN THE WORLD


The cheetah is the fast animal in the world; yet it has never managed to chase out every other animal from the forest. The cheetah is an atypical member of the cat family (Felidae) that is unique in its speed, while lacking climbing abilities. The species is the only living member of the genus Acinonyx. It is the fastest land animal, reaching speeds between 112 and 120 km/h (70 and 75 mph) in short bursts covering distances up to 460 m (1,500 ft), and has the ability to accelerate from 0 to 103 km/h (64 mph) in three seconds, faster than most supercars. Recent studies confirm the cheetah’s status as the fastest land animal.

LIVING LARGE: How to travel like a billionaire!

 Inside Donald Trump's £63m private jet, complete with marble bathroom and 24-carat seat belt buckles

Most mere mortals land at Glasgow's Prestwick airport on Ryanair.
Donald Trump made an ever so slightly more glamorous arrival today on one of his Boeing 757 private jet, complete with a double bed, spacious lounge with sofas, gold finishes and marble bathroom.
The 68-year-old mogul allowed cameras inside the luxurious plane to announce a new partnership with the airport and his Trump Turnberry resort, which he acquired for an undisclosed sum earlier this year.
Scroll down for video 
Flying styles of the rich and famous: Donald Trump allowed cameras inside his Boeing 757 jet in Glasgow today
Flying styles of the rich and famous: Donald Trump allowed cameras inside his Boeing 757 jet in Glasgow today

Delta 2015: My govt will be tough on crime — Omo-Agege




November 15, 2014  
By Festus Ahon
OBAISI Ovie Omo-Agege is one of the strong contenders for the Delta State Governorship in 2015. The United States of America trained lawyer is very resolute in his aspiration to govern the State.
Omo-Agege who insists that his passion to govern is not because he is an urhobo man, said his agenda is pan-Delta with all stakeholders being carried along in his government, when elected.
In this interview, he spoke on his readiness to clinch the Governorship in 2015 among other issues of interest.
Excerpts:

Cure Achy Joints Naturally




Dr. Blaylock’s weekly Tips

One in every three American adults suffers from arthritis. It’s one of the countries leading health problems and is the leading cause of disability in Americans over the age of fifteen. Although numerous pharmaceuticals are prescribed to ease the pain of arthritis, supplements, including plant extracts and vitamins, can reduce inflammation and free radicals within the joints.

Thursday, November 13, 2014

Smart drug Modafinil may help those lacking creativity but does not help intelligent people improve results, study claims




Smart drugs can boost the performance of those who are lacking in creativity but do not help those who are academically bright, a study has found.
A survey suggested that one in five students have taken so-called “wake-up drug” Modafinil to boost their ability to study and improve their chances of exam success.
The study, published in the journal Plos One, involved 64 people, half of whom were given a placebo.
Dr Ahmed Dahir Mohamed, from the University of Nottingham, found that by taking the drug, those who were not creative were able to improve their performance in problem solving.
But healthy people functioning at the optimum level found their performance impaired.

Wednesday, November 12, 2014

DELTA TALENT: FRANZ DICKSON



Franz Dickson is clearly one of Nigeria's most admired vocalists. A singer, songwriter, voice over artiste and voice coach, he's been active in the Lagos circuit of the Nigerian music industry since the 90s. With a wealth of experience as a background vocalist for notable Nigerian artistes like Mike Okri, Alex O, Alex Zitto to mention just a few, he soon became a favorite voice for most jingle producers in Lagos Nigeria like Tunde Ajijedidun of Digitrack Studios, Kingsley Ogoro of Klink Studios, Bayo Adepetu of former Midicorp Studios e.t.c.

President Jonathan's Declaration: Full Speech


Address by His Excellency, President Goodluck Ebele Jonathan, GCFR
On the Occasion of His Declaration of Intent to Run for the 2015 Presidential Elections under the Platform of the Peoples Democratic Party (PDP) Eagle Square, Abuja
Tuesday 11th November, 2014
Gej_new.jpg
Dear Compatriots:
1. Four years ago, precisely September 18, 2010; I stood in this Eagle Square, to offer myself for election as the President of our beloved country on the platform of our great party; the Peoples Democratic Party (PDP).
2. Seven months after that declaration, you elected me to lead this country with overwhelming support from all parts of our Nation. I remain grateful for the trust you reposed in me to lead our Nation through uncommon challenges in our march of progress as a united and democratic country.

The bargain

Many hundreds of years ago in a small Italian town, a merchant had the misfortune of owing a large sum of money to the moneylender. The moneylender, who was old and ugly, fancied the merchant's beautiful daughter so he proposed a bargain. He said he would forgo the merchant's debt if he could marry the daughter. Both the merchant and his daughter were horrified by the proposal.

Experimental Ebola Drugs Face Ethical Questions Amid Clinical Trials.



Experimental Ebola Drugs Face Ethical Questions Amid Clinical Trials.
Nature (11/12, Hayden) explores the ethical concerns surrounding testing for experimental Ebola treatments. According to Nature, two trials taking place in Guinea and Liberia will announce this week whether or not some trial participants will receive a placebo during the testing for ZMapp, a treatment for Ebola. On November 11, NIH held a conference of researchers to consider US clinical trials, while on the same day in Geneva, Switzerland, the WHO held a similar meeting. The WHO concluded that because “standard of care” available in Africa is insufficient to keep patients alive, no control should be used. With plasma trials, controls can be selected among those patients for whom no serum match is available. Clifford Lane, deputy director for clinical research and special projects at NIAID said about the trials, “The idea that there’s no need for randomized, controlled trials presupposes that the drugs have zero side effects, that they are efficacious, and that there’s no substantial variability from patient to patient,” adding, “I don’t think any of that is true.”
        NPR (11/11, Harris) reports in its “Goats and Soda” blog that the meeting in Geneva will also consider how to design the trials to best meet ethical considerations and patient health. The WHO’s Martin Friede cautioned that placebo trials are met with skepticism in West Africa and notes other designs that can meet rigorous scientific challenges, saying, “This can be done through historical records, it can be through comparing what’s being done in other sites.” Friede added, “What we do not want are trials that are conducted where, at the end of the study, we are unable to say whether the drug is safe or not or whether the drug is effective or not.”
        OSU Scientist Develops Promising Ebola Treatment. The Oregonian (11/11, Terry) reports that a scientist at Oregon State University has developed a potential Ebola treatment. Patrick Iversen, the head scientist on the project, said initial trials were very promising, and that “If the epidemic lasts, I’m pretty sure we will use the drug (in Africa).” Sarepta Therapeutics, the firm behind this treatment, was in attendance at the NIH meeting on Tuesday. Sarepta has 20 courses of treatment available now and in two-three months, could have ten times that amount on hand.

Study: Experimental Hep C Treatment May Cure 97



LeadingNews

Advertisement

Study: Experimental Hep C Treatment May Cure 97% Of Liver Transplant Patients.

Bloomberg News (11/11, Chen) reports that in a “mid-stage study of 34 patients, 33 [97%] were cured of the virus after 24 weeks of treatment” using AbbVie Inc. (ABBV)’s hepatitis C treatment, an “experimental cocktail of ombitasvir, ritonavir, dasabuvir, ABT-450, and ribavirin, an antiviral drug used to supplement hepatitis C treatments.” The study, published today in the New England Journal of Medicine, involved patients “who had received a liver transplant.”
        Reuters (11/11, Penumudi) reported that in a study involving genotype 4 hepatitis C patients, the treatment was effective 100% of the time.
        Gilead: Hepatitis C Combination Treatment Cures 96-97% Of Cirrhosis Patients. Reuters (11/12, Pierson) reports that Gilead Sciences Inc. announced that its new combination hepatitis C drug Harvoni (ledipasvir/sofosbuvir), which was approved by the US FDA last month, cured 96-97% of cirrhosis patients with the genotype 1 of the virus who had failed to benefit from other treatments. In one subset of the 155 patients involved in the study, the patients took Harvoni alone for 24 weeks and were cured at a rate of 97%. In a group of patients who received Harvoni plus ribavirin for 12 weeks, the cure rate was 96%.